ArticleThe Journal of infectious diseases2025

Real-world Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in ≥50-year-old Adults With Autoimmune Diseases.

Dagna Constenla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.